Docking, Molecular Dynamics and MMPBSA Study of Selected FDA-Approved Drugs Against SARS-CoV-2 Proteases and Spike Proteins

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), rapidly evolved into a global health emergency. Despite extensive research efforts, the lack of fully effective and specific antiviral therapies during the early stages of the pan...

Descrizione completa

Dettagli Bibliografici

Autore principale:	Mohammed Nooraldeen Al-Qattan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	University of Mosul, College of Pharmacy 2026-03-01
Serie:	المجلة العراقية للصيدلة
Soggetti:	covid-19 protease spike molecular docking dynamics mmgbsa mmpbsa
Accesso online:	https://iphr.uomosul.edu.iq/article_190587_e108a8d20f41b9d4e19389355eaa7a51.pdf
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!